Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D

Expert Review of Gastroenterology & Hepatology
Sandra Maria BarbalhoMarcelo Dib Bechara

Abstract

Irritable Bowel Syndrome (IBS) is a bowel disorder leading to symptoms such as abdominal pain, modifications in the motility and bowel habits, distention, bloating, and gas. Vitamin D (VD) may interfere in a plethora of cellular mechanisms, and act directly or indirectly in the regulation of the microbiome, the release of anti-microbial peptides, modulation of the immune system and inflammation processes; which in turn, may positively interfere with the altered gut function. The main purpose of this review was to survey studies involving the impacts of VD on IBS. Area covered: Eligible studies including the term VD and IBS were searched in the MEDLINE-PubMed and EMBASE (2009-2018). VD may act direct or indirectly in the regulation of the gut microbiome, immune response, and psychosocial factors that may be included in the list of IBS triggering factors. Expert opinion: Once VD plays an essential role in many processes associated with IBS, its deficiency may be associated with IBS, and the supplementation could help in the therapeutic approach for this condition. For these reasons, the understanding of the association of VD in IBS is indispensable for the development of new strategies that could improve the quality of life of th...Continue Reading

References

May 26, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yolanda R SmithJon-Kar Zubieta
Oct 13, 2009·Expert Review of Gastroenterology & Hepatology·Eamonn M M Quigley
May 25, 2011·World Journal of Gastrointestinal Pathophysiology·Hirotada AkihoKazuhiko Nakamura
Feb 16, 2012·The American Journal of Gastroenterology·Hans TörnblomMagnus Simrén
Dec 19, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Anita SainsburyAlexander C Ford
Jan 23, 2013·Alimentary Pharmacology & Therapeutics·F KaraahmetO Yuksel
May 15, 2013·Proceedings of the National Academy of Sciences of the United States of America·Amandine EverardPatrice D Cani
Aug 24, 2013·The Journal of Nutrition·Jot Hui OoiMargherita T Cantorna
Sep 17, 2013·Molecular Nutrition & Food Research·Chunxiao GuoAdrian F Gombart
Oct 4, 2013·JPEN. Journal of Parenteral and Enteral Nutrition·Zachary A ZatorAshwin N Ananthakrishnan
Oct 11, 2013·Frontiers in Integrative Neuroscience·Augusto J Montiel-CastroGustavo Pacheco-López
Nov 15, 2013·The Australian and New Zealand Journal of Psychiatry·Lucinda J BlackWendy H Oddy
Jan 18, 2014·Journal of Gastroenterology·Robert J ShulmanMargaret M Heitkemper
May 7, 2014·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M BashashatiM Simrén
Jan 13, 2015·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·B SalvioliD Lucini
Apr 29, 2015·Nutrients·Margherita T CantornaLinlin Yang
Apr 29, 2015·Journal of Gastroenterology·Nicholas J TalleyMarjorie M Walker
May 12, 2015·Oman Medical Journal·Yasir Khayyat, Suzan Attar
Oct 16, 2015·Frontiers in Molecular Neuroscience·Anne L Lardner
Dec 15, 2015·CNS Neuroscience & Therapeutics·Rachel D MoloneyJohn F Cryan
Dec 19, 2015·Physiological Research·M BičíkováL Stárka
Dec 19, 2015·Physiological Reviews·Sylvia ChristakosGeert Carmeliet
Feb 27, 2016·Neuroscience and Biobehavioral Reviews·Walter SwardfagerRoger S McIntyre
May 3, 2016·Therapeutic Advances in Gastroenterology·Amy E Foxx-Orenstein
May 5, 2016·Gastroenterology·Giovanni BarbaraErwin G Zoetendal
May 5, 2016·Gastroenterology·Fermín MearinRobin Spiller
May 8, 2016·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·A AbbasnezhadA Ghadiri
Jun 16, 2016·The International Journal of Eating Disorders·Jennifer J Thomas, Helen B Murray
Dec 4, 2016·Molecular and Cellular Endocrinology·Antonio BarbáchanoAlberto Muñoz
Jan 31, 2017·Advances in Medical Sciences·Joanna OświęcimskaJarosław Kwiecień
Feb 14, 2017·PloS One·Benjamin Udoka NwosuNinfa Candela
Feb 17, 2017·Pharmacological Reviews·Michael J Berridge
Mar 10, 2017·Journal of Neurogastroenterology and Motility·Max J Schmulson, Douglas A Drossman
Mar 14, 2017·Metabolism: Clinical and Experimental·Renata V LutholdSandra Roberta G Ferreira
Mar 24, 2017·Scandinavian Journal of Immunology·H Alhassan MohammedA A Saboor-Yaraghi
Apr 14, 2017·The Lancet. Gastroenterology & Hepatology·Gerald J HoltmannNicholas J Talley
Apr 17, 2017·Molecular and Cellular Endocrinology·Vassil Dimitrov, John H White

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.